Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence

By sjmartinez • January 25, 2025

Krishnan S, Srivastava PK, Attaluri J, Nayeri R, Chatterjee D, Patel J, Nsair A, Budoff M, Nayeri A. Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence. J Cardiovasc Dev Dis. 2025 Jan 7;12(1):19. doi: 10.3390/jcdd12010019. PMID: 39852297; PMCID: PMC11766028.

Tags: Cardiology/Epi, GIP GLP-1 receptor agonist, Harbor UCLA, Hematology/Oncology, Metabolic syndrome, Obesity, Publications, semaglutide, tirzepatide, Veterans Administration, weight loss

Variation in mechanical circulatory support use for acute myocardial infarction cardiogenic shock

Verma A, Chervu NL, Kim JJ, Mallick S, Ziaeian B, Benharash P. Variation in mechanical circulatory support use for acute myocardial infarction cardiogenic shock. Heart.[...]

Continuous Biochemical Profiling of the Gastrointestinal Tract Using an Integrated Smart Capsule

Min J, Ahn H, Lukas H, Ma X, Bhansali R, Sunwoo SH, Wang C, Xu Y, Yao DR, Kim G, Li Z, Hsiai TK, Emami[...]

Isolated Native Pulmonary Valve Endocarditis

Mehta A, Miller S, Shah S. Isolated Native Pulmonary Valve Endocarditis. JACC Case Rep. 2025 Aug 20;30(24):104740. doi: 10.1016/j.jaccas.2025.104740. PMID: 40846383.